<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">35893043</PMID><DateCompleted><Year>2022</Year><Month>07</Month><Day>28</Day></DateCompleted><DateRevised><Year>2022</Year><Month>10</Month><Day>04</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2073-4425</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><Issue>8</Issue><PubDate><Year>2022</Year><Month>Jul</Month><Day>22</Day></PubDate></JournalIssue><Title>Genes</Title><ISOAbbreviation>Genes (Basel)</ISOAbbreviation></Journal><ArticleTitle>Frequency of Parkinson's Disease Genes and Role of <i>PARK2</i> in Amyotrophic Lateral Sclerosis: An NGS Study.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">1306</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/genes13081306</ELocationID><Abstract><AbstractText>Amyotrophic lateral sclerosis (ALS) and Alzheimer's disease (AD) patients show a higher prevalence of Lewy body disease than the general population. Additionally, parkinsonian features were found in about 30% of ALS patients. We aimed to explore the frequency of Parkinson's disease (PD)-causative genes in ALS patients, compared to AD and healthy controls (HCs). We used next-generation sequencing multigene panels by analyzing <i>SNCA</i>, <i>LRRK2</i>, <i>PINK1</i>, <i>PARK2</i>, <i>PARK7</i>, <i>SYNJ1</i>, <i>CHCHD2</i>, <i>PLA2G6</i>, <i>GCH1</i>, <i>ATP13A2</i>, <i>DNAJC6</i> and <i>FBXO</i> genes. <i>GBA</i> gene, a risk factor for PD, was also analyzed. In total, 130 ALS and 100 AD patients were investigated. PD-related genes were found to be altered in 26.2% of ALS, 20% of AD patients and 19.2% of HCs. Autosomal recessive genes were significantly more involved in ALS as compared to AD and HCs (<i>p</i> = 0.021). <i>PARK2</i> variants were more frequent in ALS than in AD and HCs, although not significantly. However, the p.Arg402Cys variant was increased in ALS than in HCs (<i>p</i> = 0.025). This finding is consistent with current literature, as parkin levels were found to be decreased in ALS animal models and patients. Our results confirm the possible role of PD-related genes as risk modifier in ALS pathogenesis.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Vacchiano</LastName><ForeName>Veria</ForeName><Initials>V</Initials><Identifier Source="ORCID">0000-0002-3607-2394</Identifier><AffiliationInfo><Affiliation>IRCCS Istituto Delle Scienze Neurologiche di Bologna, Bellaria Hospital, 40139 Bologna, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Dipartimento di Scienze Biomediche e Neuromotorie (DIBINEM), Universit&#xe0; di Bologna, 40123 Bologna, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bartoletti-Stella</LastName><ForeName>Anna</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Experimental Diagnostic and Specialty Medicine (DIMES), University of Bologna, 40138 Bologna, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rizzo</LastName><ForeName>Giovanni</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>IRCCS Istituto Delle Scienze Neurologiche di Bologna, Bellaria Hospital, 40139 Bologna, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Avoni</LastName><ForeName>Patrizia</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>IRCCS Istituto Delle Scienze Neurologiche di Bologna, Bellaria Hospital, 40139 Bologna, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Dipartimento di Scienze Biomediche e Neuromotorie (DIBINEM), Universit&#xe0; di Bologna, 40123 Bologna, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Parchi</LastName><ForeName>Piero</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0002-9444-9524</Identifier><AffiliationInfo><Affiliation>IRCCS Istituto Delle Scienze Neurologiche di Bologna, Bellaria Hospital, 40139 Bologna, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Dipartimento di Scienze Biomediche e Neuromotorie (DIBINEM), Universit&#xe0; di Bologna, 40123 Bologna, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Salvi</LastName><ForeName>Fabrizio</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>IRCCS Istituto Delle Scienze Neurologiche di Bologna, Bellaria Hospital, 40139 Bologna, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liguori</LastName><ForeName>Rocco</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>IRCCS Istituto Delle Scienze Neurologiche di Bologna, Bellaria Hospital, 40139 Bologna, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Dipartimento di Scienze Biomediche e Neuromotorie (DIBINEM), Universit&#xe0; di Bologna, 40123 Bologna, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Capellari</LastName><ForeName>Sabina</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0003-1631-1439</Identifier><AffiliationInfo><Affiliation>IRCCS Istituto Delle Scienze Neurologiche di Bologna, Bellaria Hospital, 40139 Bologna, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Dipartimento di Scienze Biomediche e Neuromotorie (DIBINEM), Universit&#xe0; di Bologna, 40123 Bologna, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>07</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Genes (Basel)</MedlineTA><NlmUniqueID>101551097</NlmUniqueID><ISSNLinking>2073-4425</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>EC 2.3.2.27</RegistryNumber><NameOfSubstance UI="D044767">Ubiquitin-Protein Ligases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.3.2.27</RegistryNumber><NameOfSubstance UI="C111567">parkin protein</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="Y">Alzheimer Disease</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020022" MajorTopicYN="N">Genetic Predisposition to Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D059014" MajorTopicYN="N">High-Throughput Nucleotide Sequencing</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010300" MajorTopicYN="Y">Parkinson Disease</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D044767" MajorTopicYN="Y">Ubiquitin-Protein Ligases</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Alzheimer&#x2019;s disease</Keyword><Keyword MajorTopicYN="N">GBA</Keyword><Keyword MajorTopicYN="N">PD-related genes</Keyword><Keyword MajorTopicYN="N">Parkinson&#x2019;s disease</Keyword><Keyword MajorTopicYN="N">amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">neurodegenerative diseases</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>5</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>6</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>6</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>7</Month><Day>27</Day><Hour>4</Hour><Minute>57</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>7</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>7</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35893043</ArticleId><ArticleId IdType="pmc">PMC9332209</ArticleId><ArticleId IdType="doi">10.3390/genes13081306</ArticleId><ArticleId IdType="pii">genes13081306</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Phukan J., Elamin M., Bede P., Jordan N., Gallagher L., Byrne S., Lynch C., Pender N., Hardiman O. The syndrome of cognitive impairment in amyotrophic lateral sclerosis: A population-based study. J. Neurol. Neurosurg. Psychiatry. 2012;83:102&#x2013;108. doi: 10.1136/jnnp-2011-300188.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2011-300188</ArticleId><ArticleId IdType="pubmed">21836033</ArticleId></ArticleIdList></Reference><Reference><Citation>Hermosura M.C., Garruto R.M. TRPM7 and TRPM2-Candidate susceptibility genes for Western Pacific ALS and PD? Biochim. Biophys. Acta. 2007;1772:822&#x2013;835. doi: 10.1016/j.bbadis.2007.02.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbadis.2007.02.008</ArticleId><ArticleId IdType="pmc">PMC1994999</ArticleId><ArticleId IdType="pubmed">17395433</ArticleId></ArticleIdList></Reference><Reference><Citation>Calvo A., Chi&#xf2; A., Pagani M., Cammarosano S., Dematteis F., Moglia C., Solero L., Manera U., Martone T., Brunetti M., et al. Parkinsonian traits in amyotrophic lateral sclerosis (ALS): A prospective population-based study. J. Neurol. 2019;266:1633&#x2013;1642. doi: 10.1007/s00415-019-09305-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-019-09305-0</ArticleId><ArticleId IdType="pubmed">30949819</ArticleId></ArticleIdList></Reference><Reference><Citation>Forrest S.L., Kim J.H., De Sousa C., Cheong R., Crockford D.R., Sheedy D., Stevens J., McCrossin T., Tan R.H., McCann H., et al. Coexisting Lewy body disease and clinical parkinsonism in amyotrophic lateral sclerosis. Eur. J. Neurol. 2021;28:2192&#x2013;2199. doi: 10.1111/ene.14849.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.14849</ArticleId><ArticleId IdType="pubmed">33793036</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Rheenen W., van der Spek R.A.A., Bakker M.K., van Vugt J.J.F.A., Hop P.J., Zwamborn R.A.J., de Klein N., Westra H.-J., Bakker O.B., Deelen P., et al. Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology. Nat. Genet. 2021;53:1636&#x2013;1648. doi: 10.1038/s41588-021-00973-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41588-021-00973-1</ArticleId><ArticleId IdType="pmc">PMC8648564</ArticleId><ArticleId IdType="pubmed">34873335</ArticleId></ArticleIdList></Reference><Reference><Citation>Giannoccaro M.P., Bartoletti-Stella A., Piras S., Pession A., De Massis P., Oppi F., Stanzani-Maserati M., Pasini E., Baiardi S., Avoni P., et al. Multiple variants in families with amyotrophic lateral sclerosis and frontotemporal dementia related to C9orf72 repeat expansion: Further observations on their oligogenic nature. J. Neurol. 2017;264:1426&#x2013;1433. doi: 10.1007/s00415-017-8540-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-017-8540-x</ArticleId><ArticleId IdType="pubmed">28620717</ArticleId></ArticleIdList></Reference><Reference><Citation>Bourinaris T., Houlden H. C9orf72 and its Relevance in Parkinsonism and Movement Disorders: A Comprehensive Review of the Literature. Mov. Disord. Clin. Pract. 2018;5:575&#x2013;585. doi: 10.1002/mdc3.12677.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mdc3.12677</ArticleId><ArticleId IdType="pmc">PMC6277362</ArticleId><ArticleId IdType="pubmed">30637277</ArticleId></ArticleIdList></Reference><Reference><Citation>Vacchiano V., Mometto N., Bartoletti-Stella A., Rizzo G., Abu-Rumeileh S., Salvi F., Parchi P., Liguori R., Capellari S. The clinical spectrum of multisystem proteinopathy: Data from a neurodegenerative cohort. J. Neurol. Sci. 2021;426:117478. doi: 10.1016/j.jns.2021.117478.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2021.117478</ArticleId><ArticleId IdType="pubmed">34020145</ArticleId></ArticleIdList></Reference><Reference><Citation>Meeus B., Verstraeten A., Crosiers D., Engelborghs S., Broeck M.V.D., Mattheijssens M., Peeters K., Corsmit E., Elinck E., Pickut B., et al. DLB and PDD: A role for mutations in dementia and Parkinson disease genes? Neurobiol. Aging. 2012;33:629.e5&#x2013;629.e18. doi: 10.1016/j.neurobiolaging.2011.10.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2011.10.014</ArticleId><ArticleId IdType="pubmed">22118943</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaikath N.N., Erskine D., Morris C.M., Majbour N.K., Vekrellis K., Li J.Y., El-Agnaf O.M.A. Heterogeneity in &#x3b1;-synuclein subtypes and their expression in cortical brain tissue lysates from Lewy body diseases and Alzheimer&#x2019;s disease. Neuropathol. Appl. Neurobiol. 2019;45:597&#x2013;608. doi: 10.1111/nan.12531.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/nan.12531</ArticleId><ArticleId IdType="pubmed">30422353</ArticleId></ArticleIdList></Reference><Reference><Citation>Petrucci S., Consoli F., Valente E.M. Parkinson Disease genetics: A &#x201c;Continuum&#x201d; from mendelian to multifactorial inheritance. Curr. Mol. Med. 2014;14:1079&#x2013;1088. doi: 10.2174/1566524014666141010155509.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1566524014666141010155509</ArticleId><ArticleId IdType="pubmed">25323865</ArticleId></ArticleIdList></Reference><Reference><Citation>Riboldi G.M., Frattini E., Monfrini E., Frucht S.J., Di Fonzo A. A Practical Approach to Early-Onset Parkinsonism. J. Parkinsons Dis. 2022;12:1&#x2013;26. doi: 10.3233/JPD-212815.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JPD-212815</ArticleId><ArticleId IdType="pmc">PMC8842790</ArticleId><ArticleId IdType="pubmed">34569973</ArticleId></ArticleIdList></Reference><Reference><Citation>Cherian A., Divya K.P. Genetics of Parkinson&#x2019;s disease. Acta Neurol. Belg. 2020;120:1297&#x2013;1305. doi: 10.1007/s13760-020-01473-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13760-020-01473-5</ArticleId><ArticleId IdType="pubmed">32813147</ArticleId></ArticleIdList></Reference><Reference><Citation>Sidransky E., Nalls M.A., Aasly J.O., Aharon-Peretz J., Annesi G., Barbosa E.R., Bar-Shira A., Berg D., Bras J., Brice A., et al. Multicenter analysis of glucocerebrosidase mutations in Parkinson&#x2019;s disease. N. Engl. J. Med. 2009;361:1651&#x2013;1661. doi: 10.1056/NEJMoa0901281.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa0901281</ArticleId><ArticleId IdType="pmc">PMC2856322</ArticleId><ArticleId IdType="pubmed">19846850</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsuang D., Leverenz J.B., Lopez O.L., Hamilton R.L., Bennett D.A., Schneider J.A., Buchman A.S., Larson E.B., Crane P.K., Kaye J.A., et al. GBA mutations increase risk for Lewy body disease with and without Alzheimer disease pathology. Neurology. 2012;79:1944&#x2013;1950. doi: 10.1212/WNL.0b013e3182735e9a.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e3182735e9a</ArticleId><ArticleId IdType="pmc">PMC3484986</ArticleId><ArticleId IdType="pubmed">23035075</ArticleId></ArticleIdList></Reference><Reference><Citation>Canosa A., Grassano M., Moglia C., Iazzolino B., Peotta L., Gallone S., Brunetti M., Barberis M., Sbaiz L., Palumbo F., et al. GBA variants influence cognitive status in amyotrophic lateral sclerosis. J. Neurol. Neurosurg. Psychiatry. 2021;28:327426. doi: 10.1136/jnnp-2021-327426.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2021-327426</ArticleId><ArticleId IdType="pmc">PMC8921570</ArticleId><ArticleId IdType="pubmed">34583942</ArticleId></ArticleIdList></Reference><Reference><Citation>Bartoletti-Stella A., Baiardi S., Stanzani-Maserati M., Piras S., Caffarra P., Raggi A., Pantieri R., Baldassari S., Caporali L., Abu-Rumeileh S., et al. Identification of rare genetic variants in Italian patients with dementia by targeted gene sequencing. Neurobiol. Aging. 2018;66:180.e23&#x2013;180.e31. doi: 10.1016/j.neurobiolaging.2018.02.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2018.02.006</ArticleId><ArticleId IdType="pubmed">29525180</ArticleId></ArticleIdList></Reference><Reference><Citation>McKenna A., Hanna M., Banks E., Sivachenko A., Cibulskis K., Kernytsky A., Garimella K., Altshuler D., Gabriel S., Daly M., et al. The Genome Analysis Toolkit: A MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res. 2010;20:1297&#x2013;1303. doi: 10.1101/gr.107524.110.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gr.107524.110</ArticleId><ArticleId IdType="pmc">PMC2928508</ArticleId><ArticleId IdType="pubmed">20644199</ArticleId></ArticleIdList></Reference><Reference><Citation>Bartoletti-Stella A., Vacchiano V., De Pasqua S., Mengozzi G., De Biase D., Bartolomei I., Avoni P., Rizzo G., Parchi P., Donadio V., et al. Targeted sequencing panels in Italian ALS patients support different etiologies in the ALS/FTD continuum. J. Neurol. 2021;268:3766&#x2013;3776. doi: 10.1007/s00415-021-10521-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-021-10521-w</ArticleId><ArticleId IdType="pmc">PMC8463338</ArticleId><ArticleId IdType="pubmed">33770234</ArticleId></ArticleIdList></Reference><Reference><Citation>Mighton C., Smith A.C., Mayers J., Tomaszewski R., Taylor S., Hume S., Agatep R., Spriggs E., Feilotter H.E., Semenuk L., et al. Data sharing to improve concordance in variant interpretation across laboratories: Results from the Canadian Open Genetics Repository. J. Med. Genet. 2022;59:571&#x2013;578. doi: 10.1136/jmedgenet-2021-107738.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jmedgenet-2021-107738</ArticleId><ArticleId IdType="pmc">PMC8523590</ArticleId><ArticleId IdType="pubmed">33875564</ArticleId></ArticleIdList></Reference><Reference><Citation>Kopanos C., Tsiolkas V., Kouris A., Chapple C.E., Albarca Aguilera M., Meyer R., Massouras A. VarSome: The human genomic variant search engine. Bioinformatics. 2019;35:1978&#x2013;1980. doi: 10.1093/bioinformatics/bty897.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/bty897</ArticleId><ArticleId IdType="pmc">PMC6546127</ArticleId><ArticleId IdType="pubmed">30376034</ArticleId></ArticleIdList></Reference><Reference><Citation>Brooks B.R., Miller R.G., Swash M., Munsat T.L., World Federation of Neurology Research Group on Motor Neuron Diseases El Escorial revisited: Revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph. Lateral Scler. Other Mot. Neuron Disord. 2000;1:293&#x2013;299. doi: 10.1080/146608200300079536.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/146608200300079536</ArticleId><ArticleId IdType="pubmed">11464847</ArticleId></ArticleIdList></Reference><Reference><Citation>Chi&#xf2; A., Moglia C., Canosa A., Manera U., D&#x2019;Ovidio F., Vasta R., Grassano M., Brunetti M., Barberis M., Corrado L., et al. ALS phenotype is influenced by age, sex, and genetics: A population-based study. Neurology. 2020;94:e802&#x2013;e810. doi: 10.1212/WNL.0000000000008869.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000008869</ArticleId><ArticleId IdType="pubmed">31907290</ArticleId></ArticleIdList></Reference><Reference><Citation>Dubois B., Feldman H.H., Jacova C., Hampel H., Molinuevo J.L., Blennow K., DeKosky S.T., Gauthier S., Selkoe D., Bateman R., et al. Advancing research diagnostic criteria for Alzheimer&#x2019;s disease: The IWG-2 criteria. Lancet Neurol. 2014;13:614&#x2013;629. doi: 10.1016/S1474-4422(14)70090-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(14)70090-0</ArticleId><ArticleId IdType="pubmed">24849862</ArticleId></ArticleIdList></Reference><Reference><Citation>Birolo G., Aneli S., Di Gaetano C., Cugliari G., Russo A., Allione A., Casalone E., Giorgio E., Paraboschi E.M., Ardissino D., et al. Functional and clinical implications of genetic structure in 1686 Italian exomes. Hum. Mutat. 2021;42:272&#x2013;289. doi: 10.1002/humu.24156.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/humu.24156</ArticleId><ArticleId IdType="pubmed">33326653</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y., Wei Q.Q., Ou R., Cao B., Chen X., Zhao B., Guo X., Yang Y., Chen K., Wu Y., et al. Genetic Variants of SNCA Are Associated with Susceptibility to Parkinson&#x2019;s Disease but Not Amyotrophic Lateral Sclerosis or Multiple System Atrophy in a Chinese Population. PLoS ONE. 2015;10:e0133776. doi: 10.1371/journal.pone.0133776.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0133776</ArticleId><ArticleId IdType="pmc">PMC4514852</ArticleId><ArticleId IdType="pubmed">26208350</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo X.Y., Chen Y.P., Song W., Zhao B., Cao B., Wei Q.Q., Ou R.W., Yang Y., Yuan L.X., Shang H.-F. SNCA variants rs2736990 and rs356220 as risk factors for Parkinson&#x2019;s disease but not for amyotrophic lateral sclerosis and multiple system atrophy in a Chinese population. Neurobiol. Aging. 2014;35:2882.e1&#x2013;2882.e6. doi: 10.1016/j.neurobiolaging.2014.07.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2014.07.014</ArticleId><ArticleId IdType="pubmed">25129240</ArticleId></ArticleIdList></Reference><Reference><Citation>Da Silva C.P., de MAbreu G., Cabello Acero P.H., Campos MJ&#xfa;nior Pereira J.S., de ARamos S.R., Nascimento C.M., Voigt D.D., Rosso A.L., Araujo Leite M.A., Vasconcellos L.F.R., et al. Clinical profiles associated with LRRK2 and GBA mutations in Brazilians with Parkinson&#x2019;s disease. J. Neurol. Sci. 2017;381:160&#x2013;164. doi: 10.1016/j.jns.2017.08.3249.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2017.08.3249</ArticleId><ArticleId IdType="pubmed">28991672</ArticleId></ArticleIdList></Reference><Reference><Citation>Wszolek Z.K., Vieregge P., Uitti R.J., Gasser T., Yasuhara O., McGeer P., Berry K., Calne D.B., Vingerhoets F.J.G., Klein C., et al. German Canadian family (family A) with parkinsonism, amyotrophy, and dementia: Longitudinal observations. Parkinsonism Relat. Disord. 1997;3:125&#x2013;139. doi: 10.1016/S1353-8020(97)00013-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1353-8020(97)00013-8</ArticleId><ArticleId IdType="pubmed">18591067</ArticleId></ArticleIdList></Reference><Reference><Citation>Whittle A.J., Ross O.A., Naini A., Gordon P., Mistumoto H., D&#xe4;chsel J.C., Stone J.T., Wszolek Z.K., Farrer M.J., Przedborski S. Pathogenic Lrrk2 substitutions and Amyotrophic lateral sclerosis. J. Neural. Transm. 2007;114:327&#x2013;329. doi: 10.1007/s00702-006-0525-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00702-006-0525-3</ArticleId><ArticleId IdType="pubmed">16865326</ArticleId></ArticleIdList></Reference><Reference><Citation>Ciani M., Bonvicini C., Scassellati C., Carrara M., Maj C., Fostinelli S., Binetti G., Ghidoni R., Benussi L. The Missing Heritability of Sporadic Frontotemporal Dementia: New Insights from Rare Variants in Neurodegenerative Candidate Genes. Int. J. Mol. Sci. 2019;20:3903. doi: 10.3390/ijms20163903.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms20163903</ArticleId><ArticleId IdType="pmc">PMC6721049</ArticleId><ArticleId IdType="pubmed">31405128</ArticleId></ArticleIdList></Reference><Reference><Citation>Caesar M., Felk S., Zach S., Br&#xf8;nstad G., Aasly J.O., Gasser T., Gillardon F. Changes in matrix metalloprotease activity and progranulin levels may contribute to the pathophysiological function of mutant leucine-rich repeat kinase 2. Glia. 2014;62:1075&#x2013;1092. doi: 10.1002/glia.22663.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.22663</ArticleId><ArticleId IdType="pubmed">24652679</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho D.H., Kim H., Nam D., Sim H., Kim J., Kim H.G., Son I., Seol W. LRRK2 impairs autophagy by mediating phosphorylation of leucyl-tRNA synthetase. Cell Biochem. Funct. 2018;36:431&#x2013;442. doi: 10.1002/cbf.3364.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cbf.3364</ArticleId><ArticleId IdType="pubmed">30411383</ArticleId></ArticleIdList></Reference><Reference><Citation>Nuytemans K., Theuns J., Cruts M., Van Broeckhoven C. Genetic etiology of Parkinson disease associated with mutations in the SNCA, PARK2, PINK1, PARK7, and LRRK2 genes: A mutation update. Hum. Mutat. 2010;31:763&#x2013;780. doi: 10.1002/humu.21277.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/humu.21277</ArticleId><ArticleId IdType="pmc">PMC3056147</ArticleId><ArticleId IdType="pubmed">20506312</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaweda-Walerych K., Sitek E.J., Naro&#x17c;a&#x144;ska E., Buratti E. Parkin beyond Parkinson&#x2019;s Disease-A Functional Meaning of Parkin Downregulation in TDP-43 Proteinopathies. Cells. 2021;10:3389. doi: 10.3390/cells10123389.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells10123389</ArticleId><ArticleId IdType="pmc">PMC8699658</ArticleId><ArticleId IdType="pubmed">34943897</ArticleId></ArticleIdList></Reference><Reference><Citation>Dilliott A.A., Abdelhady A., Sunderland K.M., Farhan S.M.K., Abrahao A., Binns M.A., Black S.E., Borrie M., Casaubon L.K., Dowlatshahi D., et al. Contribution of rare variant associations to neurodegenerative disease presentation. NPJ Genom. Med. 2021;6:80. doi: 10.1038/s41525-021-00243-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41525-021-00243-3</ArticleId><ArticleId IdType="pmc">PMC8478934</ArticleId><ArticleId IdType="pubmed">34584092</ArticleId></ArticleIdList></Reference><Reference><Citation>Lagier-Tourenne C., Polymenidou M., Hutt K.R., Vu A.Q., Baughn M., Huelga S.C., Clutario K.M., Ling S.C., Liang T.Y., Mazur C., et al. Divergent roles of ALS-linked proteins FUS/TLS and TDP-43 intersect in processing long pre-mRNAs. Nat. Neurosci. 2012;15:1488&#x2013;1497. doi: 10.1038/nn.3230.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.3230</ArticleId><ArticleId IdType="pmc">PMC3586380</ArticleId><ArticleId IdType="pubmed">23023293</ArticleId></ArticleIdList></Reference><Reference><Citation>Knippenberg S., Sipos J., Thau-Habermann N., K&#xf6;rner S., Rath K.J., Dengler R., Petri S. Altered expression of DJ-1 and PINK1 in sporadic ALS and in the SOD1(G93A) ALS mouse model. J. Neuropathol. Exp. Neurol. 2013;72:1052&#x2013;1061. doi: 10.1097/NEN.0000000000000004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/NEN.0000000000000004</ArticleId><ArticleId IdType="pubmed">24128678</ArticleId></ArticleIdList></Reference><Reference><Citation>Schapira A.H., Chiasserini D., Beccari T., Parnetti L. Glucocerebrosidase in Parkinson&#x2019;s disease: Insights into pathogenesis and prospects for treatment. Mov. Disord. 2016;31:830&#x2013;835. doi: 10.1002/mds.26616.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mds.26616</ArticleId><ArticleId IdType="pubmed">27091307</ArticleId></ArticleIdList></Reference><Reference><Citation>Guerreiro R., Ross O.A., Kun-Rodrigues C., Hernandez D.G., Orme T., Eicher J.D., Shepherd C.E., Parkkinen L., Darwent L., Heckman M.G., et al. Investigating the genetic architecture of dementia with Lewy bodies: A two-stage genome-wide association study. Lancet Neurol. 2018;17:64&#x2013;74. doi: 10.1016/S1474-4422(17)30400-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(17)30400-3</ArticleId><ArticleId IdType="pmc">PMC5805394</ArticleId><ArticleId IdType="pubmed">29263008</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang Y., Deng L., Zhong Y., Yi M. The Association between E326K of GBA and the Risk of Parkinson&#x2019;s Disease. Parkinsons Dis. 2018;2018:1048084. doi: 10.1155/2018/1048084.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2018/1048084</ArticleId><ArticleId IdType="pmc">PMC5901859</ArticleId><ArticleId IdType="pubmed">29808112</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim H.M., Nazor C., Zabetian C.P., Quinn J.F., Chung K.A., Hiller A.L., Hu S.-C., Leverenz J.B., Montine T.J., Edwards K.L., et al. Prediction of cognitive progression in Parkinson&#x2019;s disease using three cognitive screening measures. Clin. Park Relat. Disord. 2019;1:91&#x2013;97. doi: 10.1016/j.prdoa.2019.08.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.prdoa.2019.08.006</ArticleId><ArticleId IdType="pmc">PMC7197868</ArticleId><ArticleId IdType="pubmed">32368733</ArticleId></ArticleIdList></Reference><Reference><Citation>Oliveira L.M., Rastin T., Nimmo G.A.M., Ross J.P., Dion P.A., Zhang M., Nevay D.L., Arkadir D., Gotkine M., Barnett C., et al. Occurrence of Amyotrophic Lateral Sclerosis in Type 1 Gaucher Disease. Neurol. Genet. 2021;7:e600. doi: 10.1212/NXG.0000000000000600.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/NXG.0000000000000600</ArticleId><ArticleId IdType="pmc">PMC8130998</ArticleId><ArticleId IdType="pubmed">34017912</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>